Answers are grounded in this paper and cite their sources.
The TNM™ device for CVS appears to provide a clinically efficacious and highly tolerable adjuvant therapy for the prevention of episodic migraine.
No takes yet. Share an insight, caveat, or question.
Wilkinson et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: